Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study

Next Previous
Trial Profile

Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Feb 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Paracetamol
  • Indications Coronary artery disease; Myocardial infarction
  • Focus Pharmacokinetics
  • Acronyms The GASTRIM study

Most Recent Events

  • 08 Feb 2022 Status changed from recruiting to completed.
  • 24 Jan 2017 Planned End Date changed from 1 Oct 2015 to 8 Jun 2017.
  • 24 Jan 2017 Planned primary completion date changed from 1 Oct 2015 to 8 Jun 2017.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top